You signed in with another tab or window. Reload to refresh your session.You signed out in another tab or window. Reload to refresh your session.You switched accounts on another tab or window. Reload to refresh your session.Dismiss alert
Cost-effectiveness microsimulation model for IXA-001 (aldosterone synthase inhibitor) vs Spironolactone in resistant hypertension. Features dual-branch phenotyping, PA risk modifiers, AF tracking, and interactive Streamlit dashboard.
Illustrative HTA-style probabilistic cost-effectiveness analysis using Python, Monte Carlo PSA, decision uncertainty, CEAC, scenario analysis, and reproducible exports.
Budget impact model for IXA-001 in resistant hypertension. Features population funnel analysis, uptake scenarios, secondary HTN etiology stratification, and interactive Streamlit dashboard with Excel exports.
An advanced Health Economics and Outcomes Research (HEOR) engine and interactive obesity treatment calculator. Built with Python, this tool models clinical pathways, performs Probabilistic Sensitivity Analysis (PSA), and evaluates cost-effectiveness to support data-driven healthcare decision-making and pharmaceutical research